Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Novartis carries a solid financial position with a debt/2024 projected EBITDA ratio of 1.2 times. Further, its diverse portfolio of drugs should translate into steady cash flows to easily service ...

Novartis has filed a lawsuit seeking to block a Maryland law that would require drugmakers to offer discounts on drugs dispensed by third-party pharmacies that contract with hospitals and clinics ...

Novartis’ global service center in Dublin is more than just a regional office. The more than 1,000 employees currently stationed there belong to two units—Novartis Business Services and Global ...

The forum came at time when there appears to be little health messaging at the federal level.

Novartis plans to cut 285 jobs at its U.S. headquarters in East Hanover as part of a restructuring announced earlier this year by the Swiss pharma giant.. According to a notice filed with the New ...

Novartis Pharma Services AG donated US$ 200,000 to the King Hussein Cancer Foundation (KHCF) which is dedicated entirely towards the planned expansion o ...

Novartis has entered a 3-year partnership with Schrödinger, a computational chemistry services company, to discover new drugs. Novartis will gain access to Schrödinger’s wide range of drug ...

A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug Price Negotiation Program, ruling that the program does not violate ...

The head of pharma group Novartis has warned that the US government’s reform of drug pricing risks damaging public health as drugmakers have already begun to cut investment in pills for the elderly.